title: Reply to "Alanine transaminase as a single marker is not reliable for selecting candidates of pegylated interferon and ribavirin treatment".
authors.affiliation: Division of Gastroenterology, Department of Internal Medicine, Tri-Service General Hospital Songshan Branch, National Defense Medical Center, Taipei, Taiwan; Division of Gastroenterology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
authors.forename: Jung-An
authors.initials: JA
authors.lastname: Lin
authors.affiliation: Division of Gastroenterology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan. Electronic address: albreb@ms28.hinet.net.
authors.forename: Yu-Lueng
authors.initials: YL
authors.lastname: Shih
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D006467:Hemophilia A / Q000150:complications*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D012254:Ribavirin / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D011092:Polyethylene Glycols; D012254:Ribavirin